• Editorial Staff
  •  
  • Clinical Editor
  • Terry Treadwell, MD, FACS
  •  
  • Managing Editor
  • Barbara Drosey
  •  
  • Associate Editor
  • Kelsey Moroz
  •  
  • Web Editor
  • Samantha Alleman
  • Editorial Correspondence:
  •  
  • Barbara Drosey, Managing Editor, WOUNDS
  •  
  • HMP Communications, 83 General Warren Blvd
  • Suite 100, Malvern, PA 19355
  •  
  • Telephone: (800) 237-7285 or
  • (610) 560-0500, ext. 258
  • Fax: (610) 560-0501.
  • E-mail: bdrosey@hmpcommunications.com
February, 2002 | Volume 14 - Issue 2

Over Two Hundred Wound Professionals Test in 2001; Dates for 2002 Testing Sites Confirmed

Over 200 healthcare professionals interested in attaining board certification through the American Academy of Wound Management (AAWM) applied to take the National Wound Care Certification Examination at testing centers throughout the country in 2001.
Qualified candidates for certification in wound management are required to achieve a passing score on the examination in order to earn the designation Certified Wound Specialist® or CWS®. The examination covers multidisciplinary questions related to wound care that cover the areas of anatomy, diagnosis, psychosociology, general knowledge, phy...

Spenco® 2nd Skin® Products with Hyaluronan

Spenco Medical Corporation, a privately held Waco, Texas-based company, has announced the signing of an exclusive strategic alliance with Fidia SpA, a manufacturer of pharmaceuticals based on hyaluronan technology. The agreement allows Spenco the exclusive distribution rights in North America, Australia, New Zealand, and the United Kingdom to products manufactured by Fidia SpA.
The Spenco® 2nd Skin® Advanced First Aid products with Hyaluronan are the latest from Spenco Medical Corporation in wound care treatment. 2nd Skin with Hyaluronan provides a pattern for tissue repair for a shortene...

Ortec Partners with PDI for Launch of OrCel into Burn Market

Ortec International, Inc., a tissue-engineering company, announced that it will use a dedicated sales force provided by PDI, a pharmaceutical and medical device and diagnostics sales and marketing company, to target the donor site burn market. OrCel™, a biologically active wound agent, will be launched during the first quarter of 2002 throughout the United States. OrCel is the only product containing living human cells approved by the FDA for healing donor site wounds in burn patients.
Ortec International, Inc., is a tissue-engineering company involved in the commercialization of a propri...

New Testing Reveals Early Onset of Peripheral Neuropathy

The initial signs of diabetic peripheral neuropathy, one of the most common complications of diabetes, are difficult to recognize. There may be a slight tingling or numbness that comes and goes in the feet or hands. Over time, these changes will become more constant, perhaps causing an individual to be unable to know when his or her shoes are too tight or the water temperature is too hot or cold.
Changes in muscle strength will occur, eventually resulting in a loss of coordination and balance. If left untreated, peripheral neuropathy will lead to ulcerations or holes in the feet, infections...

Improve the Appearance of New and Old Scars with ScarGuard

For decades, doctors have known that using silicone gels, some types of cortisone, or pressure dressings can improve the appearance of scars. Many doctors feel vitamin E can reduce scar tissue formation by blocking the creation of more collagen.
While doctors have used each of these ingredients individually for decades to improve the appearance of scars, they are cumbersome, difficult, or messy. Patients usually stop using them, they almost never use more than one, and without regular use, their scars will not benefit.
For the first time, these ingredients have been combined into a produc...

Pruritus and Burn Wounds

Guest Editor: Robert S. Kirsner, MD

Completion Time: The estimated time to completion for this activity is 1 hour.

Target Audience: This CME activity is intended for dermatologists, surgeons, internists, and physicians who treat burn wounds.

At the conclusion of this activity, the participant should be able to:
1) Recognize the problem of itching or pruritus in the healed burn wound
2) Discuss the current theories as to pathogenesis of pruritus
3) Recognize the current treatment modalities used for pruritus, including success rate and failure
4) Dis...

Back to top